georgetown university doctor jesse goodman former chief scientist at the fda with latest on covid-19cine and coronavirus variance. on the 2021 conservative political action conference in the future of the gop. and competitive enterprise institute senior fellow john burlap talks about his book george washington, entrepreneur. watch c-span's "washington journal" live on saturday morning.

georgetown university doctor jesse goodman former chief scientist at the fda with latest on covid-19 vaccine and coronavirus variance. on the 2021 conservative political action conference in the future of the gop. and competitive enterprise institute senior fellow john burlap talks about his book george washington, entrepreneur. watch c-span's "washington journal" live on saturday morning. facebook comments, text messages and tweets. ♪ ♪ back during his trip to texas and a president toured a winter storm response unit in houston and later stopped at a coronavirus fox nation site and rg stadium. pandemic should not be part of the issue. here's governor abbott and other state officials talk about storm recovery efforts. [applause] >> evolving very politely been with me all day and it is dinner time. [laughter] good afternoon, i'm sorry it's evening. i want to thank you, governor, ms. abbott for your hospitality and your friendship. and representative senator korn i think he had to go back think he's getting on a plane. he told me when he came back to see the last event. shows surely ja

jesse goodman from georgetown university for taking time out of his morning and answering our questions. dr. goodman, thank you so much. >> you're watching c-span, your unfiltered view of government. c-span was created by america's television companies in 1979. today, we're brought to you by these television companies that bring c-span2 as a public service. >> it's been about a month since the biden administration took over in washington. the dust is starting to settle when it comes to telecommunications and tech issues. and that's what we're exploring this week on the communicators. we have a roundtable of three tech reporters. one works at cq work -- cq world -- cq roll call. and to all three of you, and we'll start with you, antitrust has become a huge issue in washington. merrick garland is going to be involved. when it comes to tech and telecommunications, where are we going with antitrust issues? >> thanks for having me on this program. i would think antitrust is a long, slow burn issue, if you especially look at the previous experience on how the government has dealt with antitru

jesse goodman from georgetown university for taking time out of his morning and answering our questions. dr. goodman, thank you so much. >> you're watching c-span, your unfiltered view of government. c-span was created by america's television companies in 1979. today, we're brought to you by these television companies that bring c-span2 as a public service. >> it's been about a month since the biden administration took over in washington. the dust is starting to settle when it comes to telecommunications and tech issues. and that's what we're exploring this week on the communicators. we have a roundtable of three tech reporters.

jesse goodman, the former scientist at the fda.e is here to discuss covid-19 vaccines and coronavirus. good morning. let's get to the current news. yesterday, the fda committee approved the johnson & johnson vaccine for emergency use authorization. tell us what that means. what happens now? guest: it means the fda weighed the evidence for large clinical trial of over 40,000 people and determined it was safe and effective in reducing covid-19 illness. that means if the fda goes along with the advisory committee deliberations, that vaccine will become available relatively quickly, as early as next week. the company has going to be ramping up significantly and increase the vaccine supply. it's good news. host: what are the differences between the johnson & johnson vaccine and the ones that we have heard so much about, the ones being used right now? guest: one big difference is it is one dose. that makes things much simpler. it also doesn't have to be stored at ultra frozen temperatures. that makes use simpler. it is less effective for

the news of the day and discussing policy issues that impact you were coming up saturday morning jesse goodmanef scientist at the fda. corona virus variance within "washington post" national political reporter david on the 2021 political action conference in the future of the gop. and competitive enterprise institute senior fellow, john blau talks about his book george washington entrepreneur. watch c-span's "washington journal" levitt seven eastern saturday morning. facebook comments, text messages and tweets. it is the fbi director christopher way regarding the fbi security planning in advance of generally six whites are live coverage at 10:00 a.m. eastern on c-span three rate and c-span.org printer listen live on the c-span radio app. : : : >> good morning. welcome to the